Spero Therapeutics Inc logo

Spero Therapeutics Inc (SPRO)

$1.2

Spero Therapeutics Inc (SPRO) Share Price Forecast
Currently 10 wall-street analysts regularly analyze the financials of Spero Therapeutics Inc on a frequent basis to provide recommendations along with target share price. 10 analysts offering 12-month price forecasts for Spero Therapeutics Inc (SPRO) have a share price target of $6.67. This median of share price forecast represents a 455.83% upside from the latest price of $1.2 as on 30.09.23.

Spero Therapeutics Inc (SPRO) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Spero Therapeutics Inc (SPRO) share price will touch around $6.67 in next 12-months.
Spero Therapeutics Inc (SPRO) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Spero Therapeutics Inc's share price and its median forecast price. As on 30.09.23, the difference is -77.21%

Spero Therapeutics Inc (SPRO): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Spero Therapeutics Inc (SPRO) Share Price : Analyst Recommendation
Based on 10 analysts tracking and researching Spero Therapeutics Inc (SPRO) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
6
6
6
Outperform
2
2
2
Hold
2
2
2
Underperform
0
0
0
Sell
0
0
0
Spero Therapeutics Inc (SPRO) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Spero Therapeutics Inc (SPRO) is $6.67, offered by 10 analysts offering 12-month price forecasts.

Spero Therapeutics Inc (SPRO) has a maximum of 4.56 upside potential, based on 10 analysts offering 12-month price forecasts.

Based on 10 analysts tracking and researching Spero Therapeutics Inc (SPRO), 80% have a buy recommendation. Remaining 20% have either sell or hold recommendations.

The latest share price of Spero Therapeutics Inc (SPRO) is $1.2 as of 30/09/2023.

8 of total 10 analysts offering stock ratings for Spero Therapeutics Inc SPRO have recommended buy rating.